IFWM
JAZZ icon

Institute for Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Institute for Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35K Buy
+10
New +$2.19K ﹤0.01% 1568
2025
Q3 		– Sell
-2,110
Closed -$224K – 586
2025
Q2 		$224K Hold
2,110
– – 0.03% 511
2025
Q1 		$262K Hold
2,110
– – 0.03% 448
2024
Q4 		$260K Buy
+2,110
New +$249K 0.03% 433

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Institute for Wealth Management's JAZZ Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 10 shares worth $2.35K. The stake represents ﹤0.01% of the portfolio and ranks #1568 among its holdings. This is a return to the name: Institute for Wealth Management previously reported a position in JAZZ as recently as Q2 2025.

Institute for Wealth Management first reported a position in JAZZ in Q4 2024 and has held it in 4 quarters since. The position peaked at $262K in Q1 2025. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Institute for Wealth Management held 10 shares of Jazz Pharmaceuticals worth $2.35K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Institute for Wealth Management position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1568 holding.
  • Institute for Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Institute for Wealth Management's Jazz Pharmaceuticals position peaked at $262K in Q1 2025.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.